Ares Management Corporation ARES

Key data

The business

Ares Management is among the largest private-credit managers in the world. The core product is plain: a senior secured loan to a company earning, say, $50m to $150m a year, the kind of borrower a bank used to fund and now largely won't. Ares makes that loan out of a fund it raised from pensions, insurers, sovereign funds, and lately from wealthy individuals through non-traded vehicles. It charges roughly 1% a year to manage the money and keeps a slice of the gains. The capital is locked up for years, so the fee is close to an annuity. That is the moat: scale in origination means Ares sees more deals than anyone, picks the best, and raises the next fund more easily than a smaller rival, and the money cannot walk out the door on a bad quarter. Credit is the engine, with real estate, private equity, and a growing secondaries and infrastructure book riding alongside. Hold one thing in your head: Ares is a toll road on money looking for yield, not a fund betting its own account.

The numbers

Ares keeps two sets of books and only one matters. Under GAAP the earnings lurch around, $0.13 one quarter and $1.15 the next, because the accounting drags in the marks on funds Ares consolidates but does not own. The number the firm and its investors actually watch is realized income, the cash left after costs and taxes, and it has been a steady climb.

Read the last column, not the middle one. Realized income rose 25% over the year even as revenue growth slowed to 6% and GAAP earnings told no coherent story at all.

The 2025 revenue jump, up 67%, is the GCP acquisition landing on the books, not organic growth. Here is the tension the headline hides: over the past year Ares grew the cash it keeps per share 25%, but it printed more stock to fund deals and pay people, the diluted count rising from 219m to 226m in four quarters. The watch-item from earlier this summer was whether that issuance would slow once GCP was digested, and it has not. What I think the market underweights is the committed capital Ares has raised but is not yet earning a full fee on: as that deploys, management fees step up with no new fundraising. The print that settles it is management-fee growth reaccelerating above the 6% revenue line. If it stays at 6%, you are paying 27 times cash earnings for a business growing at the pace of a good bank.

Management

The record is strong and the insiders are selling into it. Realized income per share rose 25% over the past year and the dividend has climbed to $4.94, a 3.5% yield that rises as the cash earnings rise. Against that, the buyback looks impatient: Ares spent $946m repurchasing stock in 2025 at an average near $167, about 16% above today's $140. Insider activity runs one direction, 46 open-market sales worth $169m against $1.3m of buying over the past year, with co-founder Ressler and CEO Arougheti each selling $18m to $20m in single stretches. The bundle does not flag which sales are pre-scheduled 10b5-1 plans, so I will not call it a signal, only note that no insider is adding at this price. CEO pay near $31m runs under 6% of net income, which is not the abuse it could be at a firm this size.

How it fails or surprises you

A credit cycle Ares has not been tested through. Direct lending scaled to its current size entirely inside a benign default environment. If a real recession pushes non-accruals up across the middle-market borrowers Ares funds, performance fees vanish and the marks on its own balance-sheet investments fall with them. It shows first as rising non-accruals in the listed lending vehicle's quarterly report, and it arrives faster than the fee annuity can cushion.

The wealth channel outruns its ramp (right tail). Ares is pulling individual investors into non-traded credit and infrastructure funds, a pool an order of magnitude larger than its institutional base. The market prices the steady pension money, not a retail flood. If monthly inflows into those vehicles accelerate, assets and fees step up faster than any model built on institutional flows, and the tell is in the monthly non-traded fund sales figures.

The dilution the compounding story skips. The diluted share count has grown 24% in three years to fund acquisitions, so per-share earnings have lagged the growth in the assets Ares manages. If it keeps issuing stock for the next deal, your slice compounds slower than the franchise does, and the compounder thesis quietly becomes an asset-gatherer thesis. This is the fact that would prove the bull read wrong.

Closing thoughts

This is an uncertainty a single line resolves, not a mispricing you are stealing from someone slower. The edge, if there is one, is whether the fee on committed-but-undeployed capital converts faster than Ares dilutes you, and the quarterly management-fee growth rate is the number that tells you which way it broke. The fatter tail is modestly to the upside, because the wealth channel and the undeployed pipeline are real and only half-priced. But the left tail is the one that has never arrived, a default wave through a loan book that has only known good weather, and that is what is actually at risk against an upside that is a re-rating, not a windfall.

The bet is still that investors keep handing Ares money to lend to midsize companies, and those companies keep paying it back. What breaks it is a credit cycle in direct lending, or an issuance habit that dilutes faster than fees compound. The one pair to watch is management-fee growth against the diluted share count. If realized income per share stalls while the shares keep climbing, the compounding was in the assets, not in the piece you own.